Vitamin D and diabetes: The odd couple

Trends in Endocrinology and Metabolism

Volumn 24, Issue 11, 2013, Pages 561-568

  Van Belle, Tom L ^a   Gysemans, Conny ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GAD 65; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; IBUPROFEN; INSULIN; UNCLASSIFIED DRUG; VITAMIN D;

AUTOIMMUNE DISEASE; BODY MASS; DIET SUPPLEMENTATION; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OBESITY; PANCREAS ISLET BETA CELL; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH; VITAMIN D DEFICIENCY;

ANIMALS; DIABETES MELLITUS; DIETARY SUPPLEMENTS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84886261478     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.07.002     Document Type: Review

References (86)

1. Li L., et al. Vitamin D receptor gene polymorphisms and type 2 diabetes: a meta-analysis. Arch. Med. Res. 2013, 44:235-241.
2. Hitman G.A., et al. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 1998, 47:688-690.
3. Ogunkolade B.W., et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002, 51:2294-2300.
4. Jain R., et al. Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D. Metabolism 2012, 61:293-301.
5. Malecki M.T., et al. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp. Clin. Endocrinol. Diabetes 2003, 111:505-509.
6. Dilmec F., et al. Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population. J. Diabetes Complications 2010, 24:186-191.
7. Mezza T., et al. Vitamin D deficiency: a new risk factor for type 2 diabetes?. Ann. Nutr. Metab. 2012, 61:337-348.
8. Forouhi N.G., et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 2012, 55:2173-2182.
9. Song Y., et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013, 36:1422-1428.
10. Khan H., et al. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc. Nutr. Soc. 2013, 72:89-97.
11. Scragg R., et al. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:2813-2818.
12. Forouhi N.G., et al. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet. Med. 2007, 24:200-207.
13. Lim S., et al. Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects. Am. J. Clin. Nutr. 2013, 97:524-530.
14. Aghajafari F., et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013, 346:f1169.
15. Grimnes G., et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromso Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet. Med. 2010, 27:1107-1115.
16. Vimaleswaran K.S., et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013, 10:e1001383.
17. Drincic A.T., et al. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012, 20:1444-1448.
18. Norman A.W., et al. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980, 209:823-825.
19. Kadowaki S., Norman A.W. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J. Clin. Invest. 1984, 73:759-766.
20. de Souza Santos R., Vianna L.M. Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clin. Chim. Acta 2005, 358:146-150.
21. Wolden-Kirk H., et al. Vitamin D and diabetes: its importance for beta cell and immune function. Mol. Cell. Endocrinol. 2011, 347:106-120.
22. Wolden-Kirk H., et al. Unraveling the effects of 1,25(OH)(2)D(3) on global gene expression in pancreatic islets. J. Steroid Biochem. Mol. Biol. 2012, 136:68-79.
23. Baeke F., et al. Vitamin D insufficiency: implications for the immune system. Pediatr. Nephrol. 2010, 25:1597-1606.
24. Cheng Q., et al. Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice. Diabetologia 2013, 56:553-562.
25. Cheng Q., et al. A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia 2011, 54:2077-2081.
26. Hagstrom E., et al. Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 2007, 50:317-324.
27. Gysemans C., et al. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 2008, 57:269-275.
28. Boucher B.J. Reduced cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population; do CRP and MMP markers of inflammation reflect this finding?. Nephrol. Dial. Transplant. 2005, 20:846.
29. Nagpal J., et al. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet. Med. 2009, 26:19-27.
30. von Hurst P.R., et al. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br. J. Nutr. 2010, 103:549-555.
31. Mozaffari-Khosravi H., et al. Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus. Diabet. Med. 2012, 29:36-42.
32. Kampmann U., et al. Lack of effects of high dose colecalciferol (D3) on insulin sensitivity and metabolic markers in type 2 diabetic patients: a double-blind, randomised, placebo-controlled trial. Endocr. Abstr. 2012, 29:P214.
33. Kahn H.S., et al. Association of type 1 diabetes with month of birth among U.S. youth: The SEARCH for Diabetes in Youth Study. Diabetes Care 2009, 32:2010-2015.
34. Kalliora M.I., et al. Seasonal variation of type 1 diabetes mellitus diagnosis in Greek children. Hormones (Athens) 2011, 10:67-71.
35. Karvonen M., et al. Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia. Diabetes Care 1998, 21:1101-1109.
36. Neu A., et al. Incidence of IDDM in German children aged 0-14 years. A 6-year population-based study (1987-1993). Diabetes Care 1997, 20:530-533.
37. Svensson J., et al. Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr. Diabetes 2009, 10:248-254.
38. Moltchanova E.V., et al. Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide. Diabet. Med. 2009, 26:673-678.
39. Mohr S.B., et al. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008, 51:1391-1398.
40. Sloka S., et al. The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland. Acta Diabetol. 2010, 47:73-78.
41. Staples J.A., et al. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect. 2003, 111:518-523.
42. Karvonen M., et al. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia 1993, 36:883-892.
43. Borkar V.V., et al. Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr. Diabetes 2010, 11:345-350.
44. Pozzilli P., et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm. Metab. Res. 2005, 37:680-683.
45. Littorin B., et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006, 49:2847-2852.
46. Cooper J.D., et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011, 60:1624-1631.
47. Janner M., et al. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med. Wkly. 2010, 140:w13091.
48. Svoren B.M., et al. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J. Pediatr. 2009, 154:132-134.
49. Greer R.M., et al. Australian children and adolescents with type 1 diabetes have low vitamin D levels. Med. J. Aust. 2007, 187:59-60.
50. Bener A., et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2009, 46:183-189.
51. Hypponen E., et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
52. Wang T.J., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
53. Bailey R., et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007, 56:2616-2621.
54. Ongagna J.C., et al. Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes. Clin. Biochem. 2005, 38:415-419.
55. Zhang J., et al. Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: an update by meta-analysis. Mol. Cell. Endocrinol. 2012, 355:135-142.
56. Guo S.W., et al. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am. J. Epidemiol. 2006, 164:711-724.
57. Nejentsev S., et al. Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 2004, 53:2709-2712.
58. Kahles H., et al. Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes. Genes Immun. 2009, 10(Suppl. 1):S60-S63.
59. Ferreira G.B., et al. Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D. Proteomics 2009, 9:3752-3764.
60. Jeffery L.E., et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J. Immunol. 2012, 189:5155-5164.
61. Jeffery L.E., et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 2009, 183:5458-5467.
62. low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J. Immunol. 2011, 186:132-142.
63. Palmer M.T., et al. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J. Biol. Chem. 2011, 286:997-1004.
64. Mathieu C., et al. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 1995, 136:866-872.
65. Overbergh L., et al. 1alpha, 25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000, 49:1301-1307.
66. Gregori S., et al. A 1alpha, 25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002, 51:1367-1374.
67. Gysemans C.A., et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005, 146:1956-1964.
68. EURODIAB Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999, 42:51-54.
69. Zipitis C.S., Akobeng A.K. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 2008, 93:512-517.
70. Stene L.C., et al. Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia 2000, 43:1093-1098.
71. Brekke H.K., Ludvigsson J. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr. Diabetes 2007, 8:11-14.
72. Walter M., et al. No effect of the 1alpha, 25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 2010, 33:1443-1448.
73. Bizzarri C., et al. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 2010, 33:1962-1963.
74. Prietl B., et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases?. Isr. Med. Assoc. J. 2010, 12:136-139.
75. Haller M.J., et al. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 2009, 32:2041-2046.
76. Ludvigsson J., et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N. Engl. J. Med. 2012, 366:433-442.
77. Ross A.C., et al. The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J. Am. Diet. Assoc. 2011, 111:524-527.
78. Bland R., et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J. Steroid Biochem. Mol. Biol. 2004, 89-90:121-125.
79. Jones G., et al. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998, 78:1193-1231.
80. Berends L.M., Ozanne S.E. Early determinants of type-2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26:569-580.
81. DeFronzo R.A. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going. Am. J. Med. 2010, 123:S38-S48.
82. Van Belle T.L., et al. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 2011, 91:79-118.
83. Bluestone J.A., et al. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010, 464:1293-1300.
84. Patterson C.C., et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009, 373:2027-2033.
85. Atkinson M.A., Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 2012, 55:2868-2877.
86. Orban T., et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1). Diabetes Care 2009, 32:2269-2274.